No Data
No Data
Buy Rating Affirmed for Vivani Medical on Strong Potential of NPM-115 Implant for Metabolic Disease Treatment
EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity
EXCLUSIVE: Vivani Medical Tells Benzinga 'Clinical Development of Vivani's Exenatide Implant in Overweight and Obese Patients as Part of the Company's NPM-115 Program Remains on Track to Commence in the Fourth Quarter of 2024'
EXCLUSIVE: Vivani Medical Tells Benzinga 'Vivani's GLP-1 (Exenatide) Implant Produced Sham-implant Adjusted Liver Fat Reduction of 82% in an Obese Mouse Model From a Single Administration With Expected Twice-yearly Dosing'
EXCLUSIVE: Vivani Medical Tells Benzinga Co. Announces Preclinical Liver Fat Results With Miniature, Ultra Long-Acting GLP-1 Implant
Innovative Obesity Treatment Promises High Compliance: Buy Recommendation for Vivani Medical